ArticleBriefings in bioinformatics2026
CTMAP: an adversarial cross-modal learning framework for accurate and robust cell-type annotation in single-cell resolution spatial transcriptomics.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Recent advances in single-cell-resolution spatial transcriptomics (scST) have enabled the measurement of gene expression profiles for individual cells while preserving the spatial organization of the tissue microenvironment. However, accurate cell-type annotation remains challenging due to sparse gene coverage, platform-specific technical biases, and the difficulty of identifying rare cell populations. Here, we propose CTMAP, a deep learning-based cross-modal integration framework for robust cell-type annotation of scST cells. CTMAP employs an adversarial learning strategy to align features between scRNA-seq reference data and scST data, and performs cell-type annotation of scST cells in a shared latent space using cell-type centroids derived from the reference data. We systematically evaluated CTMAP on six real scST datasets together with their corresponding scRNA-seq reference datasets. Compared with a wide range of state-of-the-art methods, CTMAP demonstrates marked advantages in overall annotation accuracy, robustness to cell-type composition mismatch, cross-platform generalization, and sensitivity to rare cell populations. Furthermore, across a series of robustness tests involving noise injection and cell-type imbalance, CTMAP consistently exhibits strong stability and resistance to perturbations, highlighting its potential as a general and reliable solution for cell-type annotation in scST.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.